FINWIRES · TerminalLIVE
FINWIRES

FactSet Poised to Deliver Fiscal Q4 Revenue Beat, Better Fiscal 2027 Guidance, RBC Says

By

FactSet's (FDS) fiscal Q4 revenue will likely beat consensus estimates due to the strength of the company's pipeline as well as its consistent execution, RBC Capital Markets said in a note Thursday.

Analysts said their fiscal Q4 margin estimate for the company is below consensus due to higher incentive costs linked to the "robust" growth of annual subscription volume. EPS estimate, however, is above consensus due to the "strong top-line momentum and disciplined capital allocation," they added.

RBC said it expects FactSet to issue fiscal 2027 guidance calling for organic annual subscription volume growth of $115 million to $165 million, up about 4.5% to 6.5% year on year, as well as "modest margin expansion," which would lead to about 7% to 10% EPS growth.

Consensus estimates for annual subscription volume growth are at $151 million and FactSet's guidance will likely reflect "prudent conservatism against a tougher comparable period," the analysts said.

For fiscal 2027, RBC said it expects the company to issue a revenue outlook of about $2.62 billion to $2.64 billion, up by about 5.9% to 6.7% year on year, and adjusted EPS of between $19.40 and $20, up by about 8.8% to 12.2% year on year.

RBC has a sector perform rating on FactSet, while increasing the company's price target to $304 from $240.

Price: $303.68, Change: $+8.23, Percent Change: +2.79%

Related Articles

Wire

Update: Magellan Financial Group Fiscal 2026 Operating Earnings, Revenue Down; Shares Fall 12%

(Updates to add stock movement in the headline and the last paragraph)Magellan Financial Group (ASX:MFG) logged AU$0.828 in operating earnings per share for fiscal 2026, compared with AU$0.898 a year ago, a Thursday filing showed.For the 12 months ended June 30, revenue and other income was AU$195.6 million versus AU$318.9 million previously, the Australia-listed financial services firm added.The board declared a final dividend of AU$0.255 per share, payable Sept. 16 to shareholders on record as of Sept. 2. A year ago, the company paid a final dividend AU$0.259 per share and special dividend of AU$0.21 per share.The board has revised the group's dividend policy from fiscal 2027, targeting a payout ratio of 60% to 90% of operating profit after tax.The company's shares fell 12% in recent Thursday trade.

ASX:MFG
Wire

Tenable to Join S&P SmallCap 600 Index

Tenable (TENB) will join the S&P SmallCap 600 index before market open on Aug. 31, the S&P Dow Jones Indices said in a late Wednesday statement.Tenable will replace Leggett & Platt (LEG), which is being acquired by Somnigroup International (SGI), according to the statement.

$LEG$SGI$TENB
Wire

NeoGenomics Wins Expanded Medicare Coverage for RaDaR ST Immunotherapy Monitoring

NeoGenomics (NEO) said its RaDaR ST molecular residual disease assay received expanded Medicare coverage to include immunotherapy response monitoring for patients with late-stage solid tumors.The determination from the Centers for Medicare & Medicaid Services' Molecular Diagnostic Services Program is the third Medicare-covered indication for RaDaR ST, NeoGenomics said Wednesday in a statement.The coverage allows use of the assay to monitor response to immune-checkpoint inhibitor therapy, and NeoGenomics said it has two additional RaDaR ST submissions pending.NeoGenomics shares rose 2.1% in after-hours trading.

$NEO